23 Investor presentation First three months of 2021 Novo Nordisk has leading positio haemophilia DKK billion Diabetes care 700 #1 50% 600 40% 500 400 30% 300 200 100 CAGR 1 value: 10.0% 20% 10% 0 Feb 2016 Market value Feb 0% 2021 NN value market share (RHS) Global market position DKK billion 10 9 8 7 6 5 4 3 2 1 0 Feb 2019 Obesity CAGR 2 val Market v NN value Global m 1 CAGR for 5-year period; 2 CAGR for 2-year period; 3 CAGR for 5-year period; Note: Annual sales figures for haemophilia A, B and byp Source: Company reports for haemophilia market, IQVIA MAT, Feb 2021; Note: Diabetes and Obesity care market values are based NN: Novo Nordisk
Download PDF file